Keymeulen, B
163  results:
Search for persons X
?
1

IDF2022-0660 Non-HLA polymorphisms diversely impact progres..:

Vandewalle, J. ; Van der Auwera, B. ; Desouter, A....
Diabetes Research and Clinical Practice.  197 (2023)  - p. 110322 , 2023
 
?
4

Immune responses against islet allografts during tapering o..:

Huurman, V A L ; van der Torren, C R ; Gillard, P...
Clinical and Experimental Immunology.  169 (2012)  2 - p. 190-198 , 2012
 
?
9

Allograft-Specific Cytokine Profiles Associate with Clinica..:

Huurman, V.A.L. ; Velthuis, J.H.L. ; Hilbrands, R....
American Journal of Transplantation.  9 (2009)  2 - p. 382-388 , 2009
 
?
10

Relevance of cytotoxic alloreactivity under different immun..:

Roelen, D L ; Huurman, V A L ; Hilbrands, R...
Clinical and Experimental Immunology.  156 (2009)  1 - p. 141-148 , 2009
 
?
11

Restoring a functional β-cell mass in diabetes:

Pipeleers, D. ; Chintinne, M. ; Denys, B....
Diabetes, Obesity and Metabolism.  10 (2008)  - p. 54-62 , 2008
 
?
12

Identification of prediabetes in first-degree relatives at ..:

Belgian Diabetes Registry ; Truyen, I ; De Grijse, J...
Clinical and Experimental Immunology.  149 (2007)  2 - p. 243-250 , 2007
 
?
13

The age at diagnosis of type 1 diabetes continues to decrea..:

Weets, I. ; Rooman, R. ; Coeckelberghs, M....
Diabetes/Metabolism Research and Reviews.  23 (2007)  8 - p. 637-643 , 2007
 
?
15

PII-46Sitagliptin (MK-0431), a selective dipeptidyl-peptida..:

BERGMAN, A ; COTE, J ; MAES, A...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P48-P48 , 2006
 
1-15